Lv33
264 积分 2022-06-28 加入
Linperlisib Plus Chidamide in Relapsed or Refractory Cutaneous T-Cell Lymphoma
1天前
已完结
Understanding Ibrilatazar’s mechanism of action: Addressing concerns about autophagy in cancer Therapy
2天前
求助中
Gedatolisib in combination with palbociclib and endocrine therapy in women with hormone receptor-positive, HER2-negative advanced breast cancer: results from the dose expansion groups of an open-label, phase 1b study
4天前
已完结
Single-cell resolution spatial analysis of antigen-presenting cancer-associated fibroblast niches
7天前
已完结
Efficacy and safety of selumetinib in adults with neurofibromatosis type 1 and symptomatic, inoperable plexiform neurofibromas (KOMET): a multicentre, international, randomised, placebo-controlled, parallel, double-blind, phase 3 study
11天前
已完结
Inavolisib-Based Therapy in PIK3CA -Mutated Advanced Breast Cancer
14天前
已完结
Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370): a multicentre, open-label, phase 3, randomised, controlled trial
16天前
已完结
Overall survival with first-line atezolizumab in combination with vemurafenib and cobimetinib in BRAFV600 mutation-positive advanced melanoma (IMspire150): second interim analysis of a multicentre, randomised, phase 3 study
16天前
已完结
Enhancing the antitumor effect of MUC16 CART cells in ovarian cancer: The potential of oncolytic adenovirus
23天前
已完结
Zanubrutinib versus bendamustine and rituximab in untreated chronic lymphocytic leukaemia and small lymphocytic lymphoma (SEQUOIA): a randomised, controlled, phase 3 trial
24天前
已完结
皖公网安备34019202002308
